European Commission logo
Horizon Europe Cluster 3 — Civil Security & Disaster Resilience

Horizon Civil Security: Disruptive Tech Innovation

Funds two €1.5M projects that take an early-stage security technology and prove it works with the practitioners and public authorities who'd use it.

OpenEuropean CommissionEU

Most early-stage security technology never makes it out of the lab. It solves a real problem on paper, but nobody has tested it with the police, fire crews, border guards, or other agencies who'd actually use it — so it stalls at a low readiness level and never reaches the field. This topic exists to close that gap.

It's an 'open' topic, which means the work programme doesn't fix which technology

Moving a disruptive, early-stage security technology from below TRL 4 to a tested TRL 4-5, so it's ready for real-world civil security use. The work programme doesn't fix which technology — any disruptive innovation qualifies if it improves preparedness, response, or risk mitigation for civil security threats, validated together with security practitioners, public authorities, and researchers.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.5 Nov 2026
Decision timeiTypical time from the deadline to the funder's decision.22 weeks
Project durationiHow long the funded work is expected to run.
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.€3M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 25 Aug 2026Funder reference: HORIZON-CL3-2026-01-SSRI-01Source: ec.europa.eu